🔥 Breakout ↑ Rising
Business
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.
1 independently sourced, verified news trends involving Big Trial.
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 1 news category, from Aug 19, 2026 through Aug 19, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.